Metipranolol

New Directions in Glaucoma Therapy - Introductory Speech at the Metipranolol Symposium.- Receptor-mediated Effects of Drugs on the Eye.- Present Day Possibilities of Glaucoma Therapy.- Pharmacological Spectrum of Metipranolol and Experience in Clinical Use.- Suitability of Metipranolol for Glaucoma Therapy from the Pharmacological Viewpoint. Pharmacological Properties of Metipranolol in Glaucoma Therapy.- The Toxicology of Metipranolol with Particular Regard to the Eye.- Principles of Clinical Drug Trials.- The Local Anaesthetic Action of Metipranolol Versus Timolol in Patients with Healthy Eyes.- Pharmaceutical Development of Eye Drops Using the Product Betamann® as an Example.- Results of a 6 Weeks' Multicenter Double-blind Trial Metipranolol Versus Timolol.- Therapeutic Efficacy of Metipranolol Eye Drops 0.3 % Versus Timolol Eye Drops 0.25 % A Double-blind Cross-over Study.- Efficacy and Tolerance of Metipranolol - Results of a Multicenter Long-term Study.- Results of a Long-term Study with Metipranolol.- Metipranolol Eye Drops - Clinical Suitability in the Treatment of Chronic Open Angle Glaucoma.- Prophylaxis of an Iatrogenic Increase in Intraocular Pressure.- Regulating Pressure in Various Forms of Glaucoma with Metipranolol Eye Drops.- Supplementary Comments from the Discussion at the Metipranolol Symposium. Compiled and reviewed.